Community Pharmacy: New CMS DIR Rules Explained

In this podcast we discuss the recent ruling from the Centers of Medicare and Medicaid on direct and indirect remuneration fees (DIRs). ASHP’s government relations experts and our members discuss the intent and impact of these changes for pharmacy practitioners and leaders. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.